Clinicopathological Characteristics in Combined Hepatocellular-Cholangiocarcinoma: A Single Center Study in Korea
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Hana | - |
dc.contributor.author | Choi, Ki Hong | - |
dc.contributor.author | Choi, Sae-Byeol | - |
dc.contributor.author | Choi, Jong Won | - |
dc.contributor.author | Kim, Do Young | - |
dc.contributor.author | Ahn, Sang Hoon | - |
dc.contributor.author | Kim, Kyung Sik | - |
dc.contributor.author | Choi, Jin Sub | - |
dc.contributor.author | Han, Kwang-Hyub | - |
dc.contributor.author | Chon, Chae Yoon | - |
dc.contributor.author | Park, Jun Yong | - |
dc.date.accessioned | 2021-09-07T08:36:24Z | - |
dc.date.available | 2021-09-07T08:36:24Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2011-09-01 | - |
dc.identifier.issn | 0513-5796 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/111606 | - |
dc.description.abstract | Purpose: Combined hepatocellular-cholangiocarcinoma (CHCC) is an uncommon form of cancer, and its clinicopathological features have rarely been reported in detail. This study was undertaken to evaluate the clinicopathological characteristics and prognostic factors of CHCC. Materials and Methods: The clinicopathological features of patients diagnosed with CHCC at Severance Hospital between January 1996 and December 2007 were retrospectively studied by comparing them with the features of patients with hepatocellular carcinoma (HCC) or cholangiocarcinoma (CC) who had undergone a hepatic resection during the same period. Results: Forty-three patients diagnosed with CHCC were included in this study (M : F=35 : 8, median age, 55 years). According to the parameters of the American Joint Committee on Cancer staging, there were 6 (14.0%), 9 (20.9%), 25 (58.1%), and 3 (7.0%) patients with stages I, II, III, and IV cancer, respectively. Thirty-two of the 43 patients underwent resection with curative intent. After resection, 27 patients (84.4%) had tumor recurrence during the follow-up period of 18 months (range: 6-106 months), and the median time to recurrence was 13 months. Overall median survival periods after hepatic resection of CHCC, HCC and CC were 34, 103 and 38.9 months, respectively (p<0.001). The median overall survival for all patients with CHCC was 21 months, and the 5-year survival rate was 18.1%. The presence of portal vein thrombosis and distant metastasis were independent prognostic factors of poor survival. Conclusion: Even after curative hepatic resection, the presence of a cholangiocellular component appeared to be a poor prognostic indicator in patients with primary liver cancer. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | YONSEI UNIV COLL MEDICINE | - |
dc.subject | PROGNOSTIC-FACTORS | - |
dc.subject | CARCINOMA | - |
dc.subject | FEATURES | - |
dc.subject | RESECTION | - |
dc.subject | CT | - |
dc.title | Clinicopathological Characteristics in Combined Hepatocellular-Cholangiocarcinoma: A Single Center Study in Korea | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Choi, Sae-Byeol | - |
dc.identifier.doi | 10.3349/ymj.2011.52.5.753 | - |
dc.identifier.scopusid | 2-s2.0-79960989617 | - |
dc.identifier.wosid | 000294196400007 | - |
dc.identifier.bibliographicCitation | YONSEI MEDICAL JOURNAL, v.52, no.5, pp.753 - 760 | - |
dc.relation.isPartOf | YONSEI MEDICAL JOURNAL | - |
dc.citation.title | YONSEI MEDICAL JOURNAL | - |
dc.citation.volume | 52 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 753 | - |
dc.citation.endPage | 760 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001578569 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | PROGNOSTIC-FACTORS | - |
dc.subject.keywordPlus | CARCINOMA | - |
dc.subject.keywordPlus | FEATURES | - |
dc.subject.keywordPlus | RESECTION | - |
dc.subject.keywordPlus | CT | - |
dc.subject.keywordAuthor | Combined hepatocellular and cholangiocarcinoma | - |
dc.subject.keywordAuthor | hepatocellular carcinoma | - |
dc.subject.keywordAuthor | cholangiocarcinoma | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.